McAdam, LLC Buys SCHWAB STRATEGIC T, Trimble Inc, PowerShares QQQ Trust Ser 1, Sells Quidel Corp, Silk Road Medical Inc, SCHWAB STRATEGIC T

• New Purchases: FNDE, TRMB, QQQ, TSLA, NLY, XLG, SBUX, VGT, DKNG, BRK.B, XLV, VIG, PSTH, V, LOW, KO, VOE, VSTM, AVGR, MARK,
• Added Positions: SCHZ, SCHX, SCHF, FNDX, SCHG, SCHC, SPTL, MDYG, RSP, TFI, SCHR, SLYG, PHB, CORP, FNDA, SLYV, VTEB, PGX, SCHP, HYMB, CWB, SCHD, BKLN, IVV, MUB, SCHM, FMCI, SHM, EFA, SCZ, PFE, MSFT, LMT, SCHA, VB, VOO, XLY, SPEM, MMM, PCY, INTC, ABBV, TTOO, FSKR, AGG, IWP, IWS, MNA, PIN, NKE, BAC, BA, CSCO, VBR, XOM, HD, SPY, IBM, IEMG, DIS, SCHB, CLNC, EMB, HYG,
• Reduced Positions: QDEL, SILK, VTI, DT, VZ, T, JNJ, CLVS, AAPL, IEF, MGC, SPYV, BMY, ORCL, BIIB, PZA, VNQ, VONG,
• Sold Out: SCHE, ITRM,

For the details of McAdam, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/mcadam%2C+llc/current-portfolio/portfolio

1. SCHWAB STRATEGIC T (SCHX) - 804,417 shares, 13.54% of the total portfolio. Shares added by 3.57%
2. SCHWAB STRATEGIC T (FNDX) - 1,349,024 shares, 10.91% of the total portfolio. Shares added by 4.36%
3. SCHWAB STRATEGIC T (SCHG) - 443,611 shares, 10.66% of the total portfolio. Shares added by 3.46%
4. SCHWAB STRATEGIC T (SCHZ) - 710,695 shares, 8.32% of the total portfolio. Shares added by 7.45%
5. SCHWAB STRATEGIC T (SCHF) - 1,057,213 shares, 6.93% of the total portfolio. Shares added by 7.13%

McAdam, LLC initiated holding in SCHWAB STRATEGIC T. The purchase prices were between $23.37 and $25.29, with an estimated average price of $24.55. The stock is now traded at around $26.67. The impact to a portfolio due to this purchase was 3.48%. The holding were 702,075 shares as of .

McAdam, LLC initiated holding in PowerShares QQQ Trust Ser 1. The purchase prices were between $250.49 and $302.76, with an estimated average price of $271.11. The stock is now traded at around $290.38. The impact to a portfolio due to this purchase was 0.09%. The holding were 1,629 shares as of .

McAdam, LLC initiated holding in Trimble Inc. The purchase prices were between $41.66 and $54.31, with an estimated average price of $47.73. The stock is now traded at around $58.31. The impact to a portfolio due to this purchase was 0.09%. The holding were 9,000 shares as of .

McAdam, LLC initiated holding in Tesla Inc. The purchase prices were between $223.93 and $498.32, with an estimated average price of $353.47. The stock is now traded at around $489.61. The impact to a portfolio due to this purchase was 0.07%. The holding were 742 shares as of .

McAdam, LLC initiated holding in DraftKings Inc. The purchase prices were between $29.5 and $58.84, with an estimated average price of $38.76. The stock is now traded at around $48.23. The impact to a portfolio due to this purchase was 0.06%. The holding were 4,733 shares as of .

McAdam, LLC initiated holding in Starbucks Corp. The purchase prices were between $72.65 and $88.38, with an estimated average price of $79.77. The stock is now traded at around $97.01. The impact to a portfolio due to this purchase was 0.06%. The holding were 3,152 shares as of .

McAdam, LLC added to a holding in VANGUARD MUNICIPAL by 38.62%. The purchase prices were between $54.07 and $55.05, with an estimated average price of $54.57. The stock is now traded at around $54.86. The impact to a portfolio due to this purchase was 0.07%. The holding were 22,251 shares as of .

McAdam, LLC added to a holding in Forum Merger II Corp by 42.78%. The purchase prices were between $13.12 and $28, with an estimated average price of $18.25. The stock is now traded at around $24.07. The impact to a portfolio due to this purchase was 0.03%. The holding were 18,205 shares as of .

McAdam, LLC added to a holding in Lockheed Martin Corp by 36.88%. The purchase prices were between $339.96 and $398.07, with an estimated average price of $381.38. The stock is now traded at around $368.02. The impact to a portfolio due to this purchase was 0.02%. The holding were 913 shares as of .

McAdam, LLC added to a holding in Pfizer Inc by 23.88%. The purchase prices were between $31.7 and $37.19, with an estimated average price of $34.96. The stock is now traded at around $36.70. The impact to a portfolio due to this purchase was 0.02%. The holding were 10,707 shares as of .

McAdam, LLC added to a holding in VANGUARD INDEX FDS by 32.94%. The purchase prices were between $285.37 and $328.74, with an estimated average price of $304.53. The stock is now traded at around $326.49. The impact to a portfolio due to this purchase was 0.02%. The holding were 1,578 shares as of .

McAdam, LLC added to a holding in T2 Biosystems Inc by 204.54%. The purchase prices were between $1.15 and $2.1, with an estimated average price of $1.48. The stock is now traded at around $1.13. The impact to a portfolio due to this purchase was 0.01%. The holding were 77,810 shares as of .

McAdam, LLC sold out a holding in SCHWAB STRATEGIC T. The sale prices were between $24.69 and $27.71, with an estimated average price of $26.7.

McAdam, LLC sold out a holding in Iterum Therapeutics PLC. The sale prices were between $0.58 and $1.22, with an estimated average price of $0.89.